Physician profile
Mark D Miller
NPI 1821167404
$7,812.95
in general payments reported to CMS, 2019-2025
23 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,308 · 2020: $1,126 · 2021: $621 · 2022: $956 · 2023: $1,108 · 2024: $1,370 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Entertainment: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,634.88 |
| Entertainment | $166.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,713.65 | 2019-2025 | Precision7, Total30 |
| Coopervision INC. | $1,321.54 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Johnson & Johnson Vision Care, INC. | $696.45 | 2019-2025 | Acuvue |
| Optos, INC. | $679.98 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $587.49 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $446.45 | 2023-2025 | Infuse, Lotemax Sm, Vyzulta |
| Lkc Technologies, INC. | $379.29 | 2023-2025 | |
| Allergan, INC. | $313.90 | 2020-2022 | |
| Maculogix, INC. | $289.92 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $289.85 | 2024-2025 | Xdemvy |
| Lumenis Be INC | $142.06 | 2023 | M22 |
| Biotissue Holdings INC. | $128.63 | 2020-2025 | |
| Oyster Point Pharma, INC. | $128.17 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $117.40 | 2020-2025 | |
| Topcon Healthcare, INC. | $107.12 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $107.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $104.91 | 2019-2023 | |
| Abbvie INC. | $57.80 | 2023 | |
| Alcon Research LLC | $56.73 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $54.31 | 2023 | Lipiflow System Activator (Disposable) |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec, INC. | $30.10 | 2019-2020 | |
| Shire North American Group INC | $21.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.